C-Reactive Protein-to-Albumin Ratio and Hospital-Recorded Mortality in Patients with ICD-10-Coded Acute Kidney Injury: A Retrospective Cohort Study
5 affiliations
- 1Department of Emergency Medicine, İstanbul Göztepe Prof. Dr. Süleyman Yalçın City Hospital, 34722 Istanbul, Türkiye
- 2Department of Emergency Medicine, Bandırma Onyedi Eylül University, 10200 Bandırma, Türkiye
- 3Institute of Biological Sciences, The John Paul II Catholic University of Lublin, 20-708 Lublin, Poland
- 4Institute of Medical Science, Collegium Medicum, The John Paul II Catholic University of Lublin, 20-708 Lublin, Poland
- 5Henry J.N. Taub Department of Emergency Medicine, Baylor College of Medicine, Houston, TX 77030, USA
Abstract
Background: The prognostic value of the C-reactive protein-to-albumin ratio (CAR) relative to its components in acute kidney injury (AKI) is uncertain. Methods: We analyzed 7181 patient-date encounters (5744 patients; 2016–2025) identified using ICD-10 codes N17.x after exclusion of coded chronic kidney disease; AKI could not be verified against KDIGO criteria. The primary outcome was hospital-recorded death within 30 days, with 180-day mortality exploratory. Age- and sex-adjusted associations and discrimination of CAR, C-reactive protein (CRP), and albumin were evaluated in a common complete-marker sample, with sensitivity and patient-level bootstrap analyses. Results: CAR was available in 6603 encounters; hospital-recorded 30-day mortality was 9.6%. Each doubling of CAR was associated with higher odds of recorded death (adjusted odds ratio 1.25, 95% confidence interval 1.20–1.29). Areas under the receiver operating characteristic curve were 0.722 for albumin, 0.659 for CAR, and 0.642 for CRP. Separately modeled components outperformed CAR in adjusted models (0.737 versus 0.688; bootstrap 95% confidence interval for the difference, 0.034–0.065). CAR performance was attenuated in hospitalized-only analyses. Conclusions: CAR was associated with hospital-recorded mortality in code-identified AKI but did not outperform albumin. External validation is required; out-of-system deaths may have been missed. CAR should not be used as a stand-alone clinical decision tool.
Related
- Prognostic Value of the C-Reactive Protein-to-Albumin Ratio in Patients Hospitalized with Atrioventricular Block: Association with In-Hospital Mortality and Temporary Pacemaker Requirement
- Admission C-reactive protein-to-albumin ratio and serum creatinine in relation to in-hospital mortality in non-HIV tuberculous meningitis: a retrospective cohort study.
- Association Between the Naples Prognostic Score and In-Hospital Mortality in Patients with Type 2 Cardiorenal Syndrome: A Retrospective Cohort Study
- Hemoglobin-to-red blood cell distribution width ratio and in-hospital mortality in patients with non-traumatic subarachnoid hemorrhage: a retrospective cohort study
- Index-window C-reactive protein and carcinoembryonic antigen and five-year all-cause mortality in Hispanic/Latino and non-Hispanic White patients with colorectal cancer: a retrospective biomarker cohort study.
BibTeX
@article{ayten2026creactive,
title = {{C-Reactive Protein-to-Albumin Ratio and Hospital-Recorded Mortality in Patients with ICD-10-Coded Acute Kidney Injury: A Retrospective Cohort Study}},
author = {Sema Ayten and Vehbi Özaydın and Hülya Yılmaz Başer and Maciej Maslyk and Lukasz Szarpak and Onur İncealtin and Cihad Ünsal Karahaliloğlu and Michal Pruc},
journal = {Journal of Clinical Medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15218422},
url = {https://www.mdpi.com/2077-0383/15/21/8422},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - C-Reactive Protein-to-Albumin Ratio and Hospital-Recorded Mortality in Patients with ICD-10-Coded Acute Kidney Injury: A Retrospective Cohort Study
AU - Sema Ayten
AU - Vehbi Özaydın
AU - Hülya Yılmaz Başer
AU - Maciej Maslyk
AU - Lukasz Szarpak
AU - Onur İncealtin
AU - Cihad Ünsal Karahaliloğlu
AU - Michal Pruc
PY - 2026
DA - 2026/10/29
JO - Journal of Clinical Medicine
DO - 10.3390/jcm15218422
UR - https://www.mdpi.com/2077-0383/15/21/8422
AB - Background: The prognostic value of the C-reactive protein-to-albumin ratio (CAR) relative to its components in acute kidney injury (AKI) is uncertain. Methods: We analyzed 7181 patient-date encounters (5744 patients; 2016–2025) identified using ICD-10 codes N17.x after exclusion of coded chronic kidney disease; AKI could not be verified against KDIGO criteria. The primary outcome was hospital-recorded death within 30 days, with 180-day mortality exploratory. Age- and sex-adjusted associations and discrimination of CAR, C-reactive protein (CRP), and albumin were evaluated in a common complete-marker sample, with sensitivity and patient-level bootstrap analyses. Results: CAR was available in 6603 encounters; hospital-recorded 30-day mortality was 9.6%. Each doubling of CAR was associated with higher odds of recorded death (adjusted odds ratio 1.25, 95% confidence interval 1.20–1.29). Areas under the receiver operating characteristic curve were 0.722 for albumin, 0.659 for CAR, and 0.642 for CRP. Separately modeled components outperformed CAR in adjusted models (0.737 versus 0.688; bootstrap 95% confidence interval for the difference, 0.034–0.065). CAR performance was attenuated in hospitalized-only analyses. Conclusions: CAR was associated with hospital-recorded mortality in code-identified AKI but did not outperform albumin. External validation is required; out-of-system deaths may have been missed. CAR should not be used as a stand-alone clinical decision tool.
SN - 2077-0383
ER -